Dissapointing market response to todays announcement.Biota should be one of the shining stars of the Australian biotech sector.
Unfortunately positive news is used as an opportunity to dump her.Management not up to standard here.
TA looks good and another round of government stockpiling coming up.GSK have managed to secure a second shot at this thanks to the ongoing problems with tamiflu.With a declining product pipeline I wouldn't imagine relenza being mishandled this time around.
big uk order, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)